AEGiS-UNAIDS: Call for urgent action to improve coverage of HIV services for injecting drug users

Important note: Information in this article was accurate in 2010. The state of the art may have changed since the publication date.

Call for urgent action to improve coverage of HIV services for injecting drug users

UNAIDS - 10 March 2010

A review carried out by the 2009 Reference Group to the UN on HIV and Injecting Drug Use for the first time quantifies the scale of coverage of HIV prevention, treatment, and care services for injecting drug users (IDUs) worldwide. The study concludes that with, specific exceptions, worldwide coverage of these services in IDU populations is very low and unlikely to be sufficient to prevent, halt, or turn around HIV epidemics.

The paper, published by The Lancet in its online edition of 1 March 2010, also highlights the need for improved data collection on injecting drug users in each region in order to get a clearer picture of the extent of their needs. "We still do not know enough about the nature and size of the populations we need to target."

Already the gaps in services are apparent. In prevention, the study estimates that two needles per month were distributed per person who injects drugs. In the countries that estimate the number of condoms distributed to IDUs, an average of 12 condoms were distributed to each IDU per year.

These global averages hide even greater regional and national variations in services.

While nearly all countries in western and eastern Europe, central Asia, Australasia, and North America had needle and syringe programmes (NSPs), these services aren't present in nine of 25 countries in east, southeast, and south Asia where injecting drug use occurs. NSPs were also absent or unreported in 14 of the 16 countries in sub-Saharan Africa where injecting drug use occurs.

Opioid substitution therapy (OST) coverage also varied from 1% or less of IDUs in central Asia, Latin America, and sub-Saharan Africa, to very high levels of 61% in western Europe.

Access to services for all drug users

UNAIDS believes that drug users can be protected from becoming infected with HIV if comprehensive, evidence-informed and human-rights-based interventions are made accessible to all drug users.

"Effective harm reduction approaches include access to clean needles, opioid substitution therapy for opiate users, access to antiretroviral therapy and reducing sexual transmission of HIV from drug users to their sexual partners through condom promotion," said UNAIDS Executive Director Michel Sidibe. "But current coverage of these services is appallingly low."

The study was funded by the UN Office on Drugs and Crime (UNODC), Australian National Drug and Alcohol Research Centre, University of New South Wales; and Australian National Health and Medical Research Council.

Resources:

Cosponsors:

UNODC - http://www.unodc.org/

Speeches:

Read UNAIDS Executive Director's speech at the 53rd session of the Commission on Narcotic Drugs (10 March 2010) - http://data.unaids.org/pub/SpeechEXD/2010/20100310_SP_CNDcaseforh armreduction_en.pdf

Feature stories:

OPINION: HIV and drugs: two epidemics - one combined strategy (20 April 2009) - http://www.unaids.org/en/KnowledgeCentre/Resources/FeatureStories /archive/2009/20090420_HIVand_Drugs_two_epi.asp

OPINION: Silence on harm reduction not an option (11 March 2009) - http://www.aegis.org/news/unaids/2009/UN090312.html

Injecting drug use and HIV: Interview with UNAIDS Team Leader, Prevention, Care and Support team (11 March 2009) - http://www.aegis.org/news/unaids/2009/UN090311.html

External links:

The Commission on Narcotic Drugs Fifty-third session -

The Lancet: HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage - http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10 )60232-2/fulltext

Publications:

UNAIDS Outcome Framework 2009-2011 (pdf, 396 Kb.). - http://data.unaids.org/pub/Report/2009/jc1713_joint_action_en.pdf
100310
UN100316

Copyright © 2010 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2010. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2010. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .